Taysha Gene Therapies (TSHA) Stock Insights

TSHA price $4.21 -0.04 -0.91%

Ticker
TSHA
Price
$4.21
Change
-0.04 -0.91%
Market cap ?
$1.37B
Beta ?
1.17
Sector
Healthcare
Industry
Biotechnology

Fair value

TSHA fair value $7.43. Price $4.21. Price is 43% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 3.21M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.75% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 324.86M. Net debt -301.60M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare TSHA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-0.13—755.56K
2026-08-11-0.13-0.11—680.00K
2026-05-06-0.12-0.10—755.56K
2026-03-19-0.08-0.115.48M2.24M
2025-11-04-0.09-0.09—1.89M
2025-08-12-0.09-0.071.99M1.73M
2025-05-15-0.08-0.082.30M1.08M
2025-02-26-0.07-0.082.02M2.05M
2024-11-13-0.09-0.081.79M2.05M
2024-08-12-0.09-0.101.11M2.66M
2024-05-14-0.10-0.113.41M2.56M
2024-03-190.35-0.093.60M2.65M
2023-11-14-0.13-0.174.75M2.33M
2023-08-14-0.38-0.312.40M1.05M
2023-05-11-0.28-0.354.71M70.00K
2023-03-28-0.99-0.412.50M8.18M
2022-11-08-0.64-0.89——
2022-08-11-0.84-1.05——
2022-05-16-1.31-1.04——
2022-03-31-1.32-1.21——
2021-11-10-1.35-1.02——
2021-08-16-1.09-0.81——
2021-05-11-0.87-0.54——
2021-03-03-1.04-0.37——
2020-11-12-1.28-0.17——
2020-09-25-0.09———
2020-06-30-0.15———
2019-12-31-0.02———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-10Nagendran SukumarSell200.00K$6.241.25M
2026-06-01Stalfort John A IIIBuy21.34K——
2026-06-01Stalfort John A IIIBuy42.67K$5.97254.75K
2026-06-01Donenberg Phillip B.Buy21.34K——
2026-06-01Donenberg Phillip B.Buy42.67K$5.97254.75K
2026-06-01Long Alison SBuy21.34K——
2026-06-01Long Alison SBuy42.67K$5.97254.75K
2026-06-01Sepp-Lorenzino LauraBuy21.34K——
2026-06-01Sepp-Lorenzino LauraBuy42.67K$5.97254.75K
2026-04-10Nagendran SukumarBuy19.02K$1.7132.53K
2026-04-10Nagendran SukumarSell200.00K$4.46892.00K
2026-04-10Nagendran SukumarSell19.02K$1.7132.53K
2026-02-04Alam KamranSell1.66K$4.527.48K
2026-01-26Nagendran SukumarSell26.92K$4.61124.09K
2026-01-26Nolan Sean P.Sell41.31K$4.61190.45K
2026-01-26Alam KamranSell23.85K$4.61109.94K
2026-01-23Nagendran SukumarSell89.13K$4.75423.38K
2026-01-23Nolan Sean P.Sell136.79K$4.75649.75K
2026-01-23Alam KamranSell78.97K$4.75375.10K
2026-01-12Alam KamranBuy359.00K——
2026-01-12Alam KamranBuy231.00K$4.861.12M
2026-01-12Nolan Sean P.Buy1.01M——
2026-01-12Nolan Sean P.Buy648.00K$4.863.15M
2026-01-12Nagendran SukumarBuy427.00K——
2026-01-12Nagendran SukumarBuy88.68K$1.71151.64K
2026-01-12Nagendran SukumarBuy111.32K$0.7077.80K
2026-01-12Nagendran SukumarSell200.00K$4.71942.00K
2026-01-12Nagendran SukumarSell88.68K$1.71151.64K
2026-01-12Nagendran SukumarBuy274.00K$4.861.33M
2026-01-12Nagendran SukumarSell111.32K$0.7077.80K
2025-12-01Nagendran SukumarBuy260.05K$1.71444.68K
2025-12-01Nagendran SukumarSell260.05K$4.511.17M
2025-12-01Nagendran SukumarSell260.05K$1.71444.68K
2025-11-28Nagendran SukumarBuy39.95K$1.7168.32K
2025-11-28Nagendran SukumarBuy70.17K$0.7049.04K
2025-11-28Nagendran SukumarSell110.12K$4.75523.09K
2025-11-28Nagendran SukumarSell39.95K$1.7168.32K
2025-11-28Nagendran SukumarSell70.17K$0.7049.04K
2025-09-10Nagendran SukumarBuy41.15K$0.7028.76K
2025-09-10Nagendran SukumarSell200.00K$3.23646.00K
2025-09-10Nagendran SukumarSell41.15K$0.7028.76K
2025-08-21Nagendran SukumarSell57.05K$2.85162.60K
2025-08-21Alam KamranSell54.49K$2.85155.30K
2025-06-02Stalfort John A IIIBuy56.62K——
2025-06-02Stalfort John A IIIBuy113.25K$2.79315.39K
2025-06-02Donenberg Phillip B.Buy56.62K——
2025-06-02Donenberg Phillip B.Buy113.25K$2.79315.39K
2025-06-02Long Alison SBuy113.25K$2.79315.39K
2025-06-02Long Alison SBuy56.62K——
2025-06-02Sepp-Lorenzino LauraBuy113.25K$2.79315.39K
2025-06-02Sepp-Lorenzino LauraBuy56.62K——
2025-05-30Manning Paul BBuy750.00K$2.752.06M
2025-03-11Alam KamranSell29.84K$1.6950.43K
2025-01-02Nolan Sean P.Buy892.50K——
2025-01-02Nolan Sean P.Buy892.50K$1.851.65M
2025-01-02Nagendran SukumarBuy324.50K——
2025-01-02Nagendran SukumarBuy324.50K$1.85600.33K
2025-01-02Alam KamranBuy431.00K——
2025-01-02Alam KamranBuy431.00K$1.85797.35K
2024-06-27Manning Paul BBuy1.33M$2.253.00M
2024-05-29Stalfort John A IIIBuy49.22K——
2024-05-29Stalfort John A IIIBuy98.44K$3.17312.05K
2024-05-29Long Alison SBuy98.44K$3.17312.05K
2024-05-29Long Alison SBuy49.22K——
2024-05-29Donenberg Phillip B.Buy49.22K——
2024-05-29Donenberg Phillip B.Buy98.44K$3.17312.05K
2024-05-29Sepp-Lorenzino LauraBuy98.44K$3.17312.05K
2024-05-29Sepp-Lorenzino LauraBuy49.22K——
2024-02-02Alam KamranSell1.29K$1.511.94K
2024-01-02Alam KamranBuy590.41K——
2024-01-02Alam KamranBuy590.41K$1.711.01M
2024-01-02Nagendran SukumarBuy863.62K——
2024-01-02Nagendran SukumarBuy863.62K$1.711.48M
2024-01-02Nolan Sean P.Buy1.18M——
2024-01-02Nolan Sean P.Buy1.18M$1.712.03M
2023-12-14Alam KamranBuy187.58K$0.70131.10K
2023-12-14Nagendran SukumarBuy334.00K$0.70233.44K
2023-12-14Nolan Sean P.Buy466.55K$0.70326.07K
2023-11-17Manning Paul BBuy100.00K$1.63163.00K
2023-11-01Long Alison SBuy43.80K$2.38104.46K
2023-11-01Long Alison SOther0——
2023-08-24Alam KamranSell33.00K$2.3376.89K
2023-08-16Manning Paul BBuy16.47M$0.9014.82M
2023-08-16Stalfort John A IIIBuy50.00K——
2023-08-16Stalfort John A IIIBuy388.89K$0.90350.00K
2023-08-16Stalfort John A IIIBuy388.89K$0.90350.00K
2023-08-16Nolan Sean P.Buy444.44K$0.90400.00K
2023-08-16Donenberg Phillip B.Buy111.11K$0.90100.00K
2023-07-13Session R.A. IISell5.34K$0.703.74K
2023-07-12Session R.A. IISell80.53K$0.7157.03K
2023-06-23Session R.A. IISell18.10K$0.7012.74K
2023-06-22Sepp-Lorenzino LauraBuy36.20K$0.7226.06K
2023-06-22Reape KathleenBuy36.20K$0.7226.06K
2023-06-22Donenberg Phillip B.Buy36.20K$0.7226.06K
2023-06-22Stalfort John A IIIBuy43.80K$0.7231.54K
2023-06-22Stalfort John A IIISell0——
2023-06-22Stalfort John A IIIOther0——
2023-06-22Session R.A. IISell10.51K$0.707.38K
2023-06-21Session R.A. IISell138.96K$0.7097.63K
2023-06-20Session R.A. IISell295.65K$0.71210.21K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 216, holders +20 vs prior quarter. Ownership 81.77%.

HolderSharesChangeChange %Value
AVORO CAPITAL ADVISORS LLC23.89M2.19M+10.09%162.68M
RA CAPITAL MANAGEMENT, L.P.23.56M00.00%160.41M
GOLDMAN SACHS GROUP INC22.71M343.47K+1.54%154.68M
BLACKROCK, INC.20.69M2.33M+12.67%140.91M
VESTAL POINT CAPITAL, LP19.41M1.42M+7.86%132.22M
MORGAN STANLEY16.49M-1.48M-8.23%112.28M
RTW INVESTMENTS, LP13.56M-119.99K-0.88%92.35M
FMR LLC13.34M-984.84K-6.88%90.82M
VANGUARD CAPITAL MANAGEMENT LLC12.48M2.25M+21.96%84.98M
STATE STREET CORP11.42M212.84K+1.90%77.78M
SIREN, L.L.C.9.85M1.02M+11.51%67.06M
OCTAGON CAPITAL ADVISORS LP9.69M833.33K+9.41%66.01M
GEODE CAPITAL MANAGEMENT, LLC6.56M1.03M+18.59%44.69M
POLAR CAPITAL HOLDINGS PLC5.12M-537.21K-9.50%34.85M
MPM BIOIMPACT LLC4.50M4.50MNew30.64M
D. E. SHAW & CO., INC.4.40M-28.65K-0.65%29.95M
BAKER BROS. ADVISORS LP4.00M00.00%27.27M
WELLINGTON MANAGEMENT GROUP LLP3.98M3.35M+534.71%27.07M
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND3.89M1.00M+34.76%26.46M
GORDONMD GLOBAL INVESTMENTS LP723.18K-14.37K-1.95%24.50M
CASDIN CAPITAL, LLC3.25M00.00%22.13M
VANGUARD PORTFOLIO MANAGEMENT LLC3.14M1.12M+55.25%21.38M
ADAR1 CAPITAL MANAGEMENT, LLC3.04M61.04K+2.05%20.71M
PICTET ASSET MANAGEMENT HOLDING SA2.77M2.77MNew18.87M
ABERDEEN GROUP PLC2.33M1.31M+127.91%15.85M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Taysha Gene Therapies (TSHA) Stock Insights

TSHA$4.21-0.04 -0.91%

$1.37B

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History